ABCB1 and cancer: Importantly, this study demonstrated that CDK6 is a novel multi-functional target that may act as an on-off switch for ABCB1 expression, potentially reversing ABCB1-mediated MDR in cancers, and therefore, has significance in combination with cancer chemotherapy.